semaglutide cardiovascular news today HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Semaglutide improves cardiovascular health but

The conversation around GLP-1 medications has to expand beyond the scale, because what we are seeing clinically is that some patients experience a flattening of hedonic response that goes well beyond food, touching motivation, social engagement, and overall sense of pleasure in daily life

If you suspect you've experienced a side effect from your medication, you can report it through the MHRA Yellow Card scheme (search 'MHRA Yellow Card' or visit yellowcard.mhra.gov.uk)

Managing side effects through timing Many people experience nausea or decreased appetite in the first 24 to 48 hours after injection, with effects tapering as the week progresses

The timeframe varies based on individual factors and baseline omega 3 status

Because patients on these medications eat smaller quantities, they often prioritize higher quality when they do indulge